Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
---|
09/19/1995 | US5451609 Deacetly moxisylyte |
09/19/1995 | US5451572 Human relaxin formulation |
09/19/1995 | US5451411 Polyacrylic acid, crosslinked alginate |
09/19/1995 | US5451407 Reduction or prevention of skin irritation or sensitization during transdermal administration of a irritating or sensitizing drug |
09/19/1995 | US5451397 Crosslinked amino functional acrylic amide polymer, reducing blood cholesterol levels |
09/19/1995 | US5451205 Remove and store portion of blood of patient, administer biocompatible oxygen carrier, return blood after patient has blood loss |
09/16/1995 | CA2144591A1 Method for stabilizing pranoprofen and stable liquid preparation of pranoprofen |
09/14/1995 | WO1995024489A1 Targeted cleavage of rna using ribonuclease p targeting and cleavage sequences |
09/14/1995 | WO1995024430A2 Block and graft copolymers and methods relating thereto |
09/14/1995 | WO1995024418A1 Method of isolating and purifying a biomacromolecule |
09/14/1995 | WO1995024417A1 Nucleotide or nucleoside photoaffinity compound modified antibodies, methods for their manufacture and use thereof |
09/14/1995 | WO1995024221A1 Bioactive and/or targeted dendrimer conjugates |
09/14/1995 | WO1995024220A1 Bispecific molecules having clinical utilities |
09/14/1995 | WO1995024219A1 Veterinary formulation |
09/14/1995 | WO1995024193A1 Topical preparations |
09/14/1995 | WO1995024188A1 Slow-release tablet containing diclofenac-na |
09/14/1995 | WO1995024187A1 Plaster-shaped transdermal system with a tamoxifen derivative |
09/14/1995 | WO1995024184A1 Gas filled microspheres as magnetic resonance imaging contrast agents |
09/14/1995 | WO1995024183A1 Methods and compositions for pulmonary delivery of insulin |
09/14/1995 | WO1995024179A1 LOW pH, HYDROLYTICALLY STABLE, COSMETIC COMPOSITIONS CONTAINING ACIDIC ACTIVES |
09/14/1995 | DE4408326A1 Retardtablette mit einem Gehalt an Diclofenac-Na Release tablet containing diclofenac-Na |
09/14/1995 | DE4407995A1 Topische Zubereitungen Topical preparations |
09/14/1995 | CA2185231A1 Low ph, hydrolytically stable, cosmetic compositions containing acidic actives |
09/14/1995 | CA2185117A1 Targeted cleavage of rna using ribonuclease p targeting and cleavage sequences |
09/14/1995 | CA2185016A1 Transdermal system in the form of a patch comprising a tamoxifen derivative |
09/14/1995 | CA2184994A1 Veterinary formulation |
09/14/1995 | CA2184814A1 Block and graft copolymers and methods relating thereto |
09/14/1995 | CA2183898A1 Nucleotide or nucleosidephotoaffinity compound modified antibodies, methods for their manufacture and use thereof as diagnostics and therapeutics |
09/13/1995 | EP0671429A1 Dense star polymers and a process for producing dense star polymers |
09/13/1995 | EP0671412A1 Tumor cell invasion-inhibiting peptides and cancer metastasis inhibitors |
09/13/1995 | EP0671175A2 Sustained release compositions for treating periodontal disease |
09/13/1995 | EP0671169A1 Nanoparticles containing an active agent and a cetal-tartanic acid amides polymer, process for preparation thereof and their use |
09/13/1995 | EP0671168A1 Pharmaceutical preparation controlled to release medicinal active ingredient at targeted site in intestinal tract |
09/13/1995 | EP0671167A1 Pharmaceutical preparation controlled to release medicinal active ingredient at targeted site in intestinal tract |
09/13/1995 | EP0671165A2 Collagen-based injectable drug delivery system and its use |
09/13/1995 | EP0671162A2 Amphoteric compositions and polymeric forms of alpha hydroxyacids, and their therapeutic use |
09/13/1995 | EP0670730A1 Fusion proteins comprising tumor necrosis factor receptor |
09/13/1995 | EP0670728A1 Lipophilic peptide-based carriers for targeted drug delivery using rational drug-binding design |
09/13/1995 | EP0670725A1 Pharmaceutical compositions for use in gastrointestinal washes |
09/13/1995 | EP0670716A1 Tastemasked pharmaceutical materials |
09/13/1995 | EP0670714A1 Retinoic acid-containing compositions |
09/13/1995 | EP0670713A1 A pharmaceutical formulation |
09/13/1995 | EP0644746A4 The use of glycerin in moderating transdermal drug delivery. |
09/13/1995 | EP0529002A4 Fluorescent porphyrin, and fluorescent phthalocyanine - polyethylene glycol, polyol, and saccharide derivatives as fluorescent probes |
09/13/1995 | CN1108454A Anthracycline conjugates, their preparation and their use as antitumor agents |
09/13/1995 | CN1108137A Pharmaceutical compositions |
09/12/1995 | US5449760 Monoclonal antibodies that bind to soluble IGE but do not bind IGE on IGE expressing B lymphocytes or basophils |
09/12/1995 | US5449720 Amplification of the VB12 uptake system using polymers |
09/12/1995 | US5449670 Composition and method for the transdermal delivery of bioactive peptides |
09/12/1995 | US5449521 Supported drugs with increased dissolution rate, and a process for their preparation |
09/12/1995 | US5449513 Physical trapping type polymeric micelle drug preparation |
09/12/1995 | CA1336961C Long lasting composition of propafenone and quinidine for treatment of cardiac conditions |
09/12/1995 | CA1336958C Peroral preparation of acid-unstable compound |
09/12/1995 | CA1336957C Phospholipid-containing composition, a process for its preparation and its use as an excipient for pharmaceutical substances |
09/10/1995 | CA2144216A1 Nanoparticles containing an active substance and a ketalized polytartramidic acid, process for their preparation, and use thereof |
09/08/1995 | WO1995023854A1 IMPROVED DNase LIQUID SOLUTIONS |
09/08/1995 | WO1995023846A1 Cell-type specific gene transfer using retroviral vectors containing antibody-envelope and wild-type envelope-fusion proteins |
09/08/1995 | WO1995023605A1 Method for treating and inhibiting gastric and duodenal ulcers |
09/08/1995 | WO1995023601A1 Method and composition for topical treatment of damaged tissue using histamine phosphate as active ingredient |
09/08/1995 | WO1995023600A1 Sublingual or buccal pharmaceutical composition |
09/08/1995 | WO1995023593A1 Controlled release oxybutynin formulations |
09/08/1995 | WO1995023591A1 Oral vehicle compositions |
09/08/1995 | WO1995023586A2 Cosmetic and/or pharmaceutical preparations |
09/08/1995 | CA2184354A1 Cell-type specific gene transfer using retroviral vectors containing antibody-envelope and wild-type envelope-fusion proteins |
09/08/1995 | CA2183329A1 Method for treating and inhibiting gastric and duodenal ulcers |
09/07/1995 | DE4407015A1 Kosmetische und/oder pharmazeutische Zubereitungen Cosmetic and / or pharmaceutical preparations |
09/06/1995 | EP0670326A2 Crystalline maltosyl glucoside, and its production and use |
09/06/1995 | EP0670166A2 Formulations for orally administered pharmaceutical agents |
09/06/1995 | EP0670162A1 Pharmaceutical formulations containing raloxifere, a surfactant and a watersoluble diluent |
09/06/1995 | EP0669988A1 Angiogenesis inhibitory antibodies |
09/06/1995 | EP0669985A1 Conjugate vaccine against group b streptococcus |
09/06/1995 | EP0669982A1 Materials comprising and methods of preparation and use for ribosome-inactivating proteins |
09/06/1995 | EP0669941A1 Method of reducing multidrug resistance in cells and tissues |
09/06/1995 | EP0669940A1 Specifically crosslinked hemoglobin with free functionality |
09/06/1995 | EP0669927A1 Sequence-specific binding polymers for duplex nucleic acids |
09/06/1995 | EP0669837A1 Restrained multifunctional reagent for surface modification |
09/06/1995 | EP0629128B1 Aqueous phospholipid vesicle dispersion, process for its manufacture and use thereof |
09/06/1995 | EP0617958A4 Pharmaceutical composition having anti-alcohol, radioprotecting and anti-choleraic activity and stimulating energy metabolism, stomach mucous membrane acid-generation and secretion functions. |
09/06/1995 | EP0561815B1 Directly compressible xylitol and method |
09/06/1995 | EP0464040B1 A moderated spun fibrous system and method of manufacture |
09/06/1995 | CN1107695A Plaster without lead and its preparation |
09/05/1995 | US5447940 Reinforced collagen matrix, dispersed antibiotic, analgesic, antiinflammatory, antiseptic |
09/05/1995 | US5447936 Anticarcinogenic agents in dimethylacetamide solutions and carboxylic acids |
09/05/1995 | US5447912 Injecting the neuropeptides VIP and PHM and an adrenergic blocking agent |
09/05/1995 | US5447728 A carrier comprising an acylated amino acid; lowering iron concentration in mammals |
09/05/1995 | US5447726 Hydroxypropylmethylcellulose coating on anion exchange resin and silicon dioxide |
09/05/1995 | US5447725 Methods for aiding periodontal tissue regeneration |
09/05/1995 | CA2006425C Transdermal therapeutical system comprising norpseudoephedrine as active component |
09/05/1995 | CA1336893C Reversibly precipitable, water-soluble polymer conjugates, their preparation and use in homogeneous catalysis |
09/05/1995 | CA1336890C Amphotericin b/cholesterol sulfate composition and method |
09/05/1995 | CA1336889C Treatment of iodine deficiency diseases |
09/05/1995 | CA1336888C Urease antigen product & process |
09/05/1995 | CA1336887C Antibody-enzyme conjugates in combination with prodrugs for the delivery of cytotoxic agents to tumor cells |
09/02/1995 | CA2138607A1 Formulations for orally administered pharmaceutical agents |
08/31/1995 | WO1995023216A1 Method for preparing clonogenic fibroblasts, method for gene transfection of fibroblasts and gene-transfected fibroblasts so obtained |
08/31/1995 | WO1995023214A1 Method for stimulating profileration of colon cells using pomc¿76-103? |
08/31/1995 | WO1995022992A2 Method and compositions for increasing the serum half-life of pharmacologically active agents |
08/31/1995 | WO1995022991A2 Block copolymers |
08/31/1995 | WO1995022982A1 Cyclosporin-containing powder composition |
08/31/1995 | WO1995022977A1 Antigen-based heteropolymers and method for treating autoimmune diseases using the same |